{
  "id": 17817349,
  "title": "Investigating the therapeutic potential of soluble TREM2 interactions with Transgelin-2 in Alzheimer's disease",
  "url": "https://urgent.news/2026/11/02/investigating-the-therapeutic-potential-of-soluble-trem2-interactions",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-02T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.10.30.763206v1?rss=1"
  },
  "original_language": "en",
  "account": "A study explores the potential of harnessing soluble TREM2 interactions with Transgelin-2 as a therapeutic strategy for Alzheimer's disease. TREM2 is a receptor expressed on myeloid cells, playing a crucial role in regulating microglial function in Alzheimer's disease. Its soluble ectodomain, sTREM2, has shown promise as a neuroprotective factor. Recent research indicates that sTREM2 interacts directly with neuronal Transgelin-2 (TG2) and influences downstream tau pathology. However, the molecular basis of this interaction remains unclear. To unravel this, the researchers employed all-atom molecular dynamics simulations to define the structural mechanisms of sTREM2-TG2 binding. They discovered an electrostatically driven interface centered on the TG2 calponin homology domain, which is engaged by a binding motif on sTREM2. This surface is composed of charged anchoring residues flanked by hydrophobic contacts. The study also reveals that the AD-risk TREM2R47H variant maintains a more open, solvent-exposed CDR2 loop, redistributing interfacial contacts while preserving overall binding affinity. This finding provides a structural explanation for the reports that R47H does not worsen tau pathology in tauopathy models. The insights gained from this study led to the design of optimized sTREM2-derived peptides that surpass a previously reported therapeutic peptide in binding persistence, energetics, and replication of native TG2 contacts. These findings establish a structure-guided strategy for developing peptide modulators of the sTREM2-TG2 interaction in Alzheimer's disease.",
  "summary": "Triggering receptor expressed on myeloid cells 2 (TREM2) is a regulator of microglial function in Alzheimer's disease (AD), and its soluble ectodomain (sTREM2) has emerged as a potential neuroprotective factor. Recent work shows that sTREM2 exerts protective effects through direct interaction with neuronal transgelin-2 (TG2) and modulates downstream tau pathology, yet the molecular basis of this…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Physics World",
        "title": "Reversing Alzheimer’s disease: nanoparticle platform converts brain cells into new neurons",
        "url": "https://urgent.news/2026/11/03/reversing-alzheimers-disease-nanoparticle-platform-converts-brain",
        "published": "2026-11-03T09:00:09.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}